Dr. Pengchcheng Ha is currently serving as the General Manager of CCBR (Beijing)，Zhong Guan Cun Life Science Park，Beijing (A Danish company，conducting clinical trials in China for pharmaceutical companies in collaboration with local hospitals and in compliance with GCP).
Pengcheng Ha graduated as a M.D. from Shanghai Medical University (Now part of Fudan University) and M.S. from McGill University in Montreal,Canada.She has spent close to 30 years in clinical research/trials, preclinical research and nutrition/toxicology research, chronologically working as a Study Director/Senior Study Director at ITR Laboratories Canada Inc. (2nd largest CRO in Canada in preclinical studies), a Clinical Scientist at Theratechnologies Inc. (Montreal) and a research scientist at Chinese Centre for Disease Control. During the time abroad she gained "hands-on" experiences in the design, performance/conduct, reporting and evaluation of all relevant types of toxicity studies and Phase I-II clinical trials. Broad knowledge of international testing regulations, GCP's and GLP’s were acquired and research programs undertaken on a broad range of pharmaceutical, biotechnology products, chemicals and biomaterials.
Upon returning to China in 2005 and after 10 year’s abroad, Pengcheng started as the Director at Drug Safety Evaluation Center, Institute of Laboratory Animal Research, Chinese Academy of Medical Sciences, where she helped the center obtain cFDA GLP certification. From years 2006-2008, Pengcheng worked at the Nordic Research Central Lab (Beijing) NRCL as lab Director in Charge of overall lab operations，and eventually obtained ISO 17025 and CAP certifications for NRCL.